Genelux

GNLXNasdaq United States Health Care Biotechnology: Pharmaceutical Preparations

Market cap

$119.276 M

$2.66 -1.48%

Close of 7 Aug 2026

Revenue

$8.00K

#3647 by revenue

Earnings

-$32.1M

Loss-making

Shares outstanding

44,805,811

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Pharmaceutical Preparations — ranked by market cap

All 501 →

#297Tiziana Life SciencesTLSA$127.3M
#298BGM GroupBGM$120.3M
#299GeneluxGNLX$119.3M
#300Cumberland PharmaceuticalsCPIX$116.9M
#301Anixa BiosciencesANIX$116.4M

Where these numbers come from

Share counts and financials for Genelux are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.